Speaker

  • Xiling Shen, Terasaki Institute, USA 
Xiling Shen

Dr. Shen is a Professor and CPRIT Established Scholar in GI Medical Oncology, Co-Director of the Colorectal Cancer Moonshot at MD Anderson, and Chief Scientific Officer at the Terasaki Institute for Biomedical Innovation. Previously, he served as the Director of the Woo Center for Big Data and Precision Health and as the Hawkins Family Professor at Duke University. He earned his BS, MS, and PhD degrees from Stanford University and received the NSF Faculty Career Award at Cornell University. Dr. Shen has chaired the NCI Patient-Derived Model of Cancer Consortium, the Tissue Engineering Collaborative, and the cancer track of the 2019 Biomedical Engineering Society meeting. As the founder of several biotech startups, he has secured over $100 million in venture funding, driving the translation of technologies into clinical and drug discovery pipelines. His lab focuses on developing novel cancer therapeutics through a systems biology approach.

« Go Back

Register Now Submit Abstract